Nexalin Net Income Applicable To Common Shares from 2010 to 2026
| NXL Stock | USD 0.41 0.01 3.75% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -2 M | Current Value -2.1 M | Quarterly Volatility 1.6 M |
Check Nexalin Technology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nexalin Technology's main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.2 K, Interest Expense of 2.7 K or Selling General Administrative of 826.6 K, as well as many indicators such as Price To Sales Ratio of 142, Dividend Yield of 0.0 or PTB Ratio of 6.54. Nexalin financial statements analysis is a perfect complement when working with Nexalin Technology Valuation or Volatility modules.
Nexalin | Net Income Applicable To Common Shares | Build AI portfolio with Nexalin Stock |
Historical Net Income Applicable To Common Shares data for Nexalin Technology serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Nexalin Technology represents a compelling investment opportunity.
Latest Nexalin Technology's Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Nexalin Technology over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Nexalin Technology's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nexalin Technology's overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Nexalin Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | (4,046,438) | |
| Coefficient Of Variation | (38.56) | |
| Mean Deviation | 1,385,775 | |
| Median | (5,021,190) | |
| Standard Deviation | 1,560,450 | |
| Sample Variance | 2.4T | |
| Range | 4.4M | |
| R-Value | 0.75 | |
| Mean Square Error | 1.1T | |
| R-Squared | 0.57 | |
| Significance | 0.0005 | |
| Slope | 233,248 | |
| Total Sum of Squares | 39T |
Nexalin Net Income Applicable To Common Shares History
About Nexalin Technology Financial Statements
Nexalin Technology investors utilize fundamental indicators, such as Net Income Applicable To Common Shares, to predict how Nexalin Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -2 M | -2.1 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Nexalin Technology Correlation against competitors. For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexalin Technology. Anticipated expansion of Nexalin directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Nexalin Technology assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.67) | Revenue Per Share | Quarterly Revenue Growth (0.50) | Return On Assets | Return On Equity |
The market value of Nexalin Technology is measured differently than its book value, which is the value of Nexalin that is recorded on the company's balance sheet. Investors also form their own opinion of Nexalin Technology's value that differs from its market value or its book value, called intrinsic value, which is Nexalin Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexalin Technology's market value can be influenced by many factors that don't directly affect Nexalin Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Nexalin Technology's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Nexalin Technology should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Nexalin Technology's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.